Home
News
Create
Screeners
Insights
Kobo Biotech
2.
74
+0.12
(+4.58%)
Market Cap
₹6.48 Cr
PE Ratio
-1.24
Industry
Chemicals
Buy
Sell
Company Performance:
1D
+4.58%
1M
+11.38%
6M
+8.73%
1Y
-2.84%
5Y
-56.99%
View Company Insights
Latest news about Kobo Biotech
Kobo Biotech Limited Submits SEBI Compliance Certificate for Quarter Ended March 31, 2026
1 day ago
Kobo Biotech Limited filed its quarterly compliance certificate under SEBI Regulation 74(5) for the quarter ended March 31, 2026, with BSE Limited on April 15, 2026. The certificate, submitted by Resolution Professional IP Namrata Amol Randeri, was supported by confirmation from registrar XL Softech Systems Ltd. regarding proper dematerialization processes and compliance with regulatory requirements during the quarter.
Kobo Biotech Limited Confirms Non-Large Corporate Status Under SEBI Framework
1 day ago
Kobo Biotech Limited's Committee of Creditors Approves Multiple Resolutions, Including CIRP Extension and Professional Fees
Oct 31, 2025
Kobo Biotech's Committee of Creditors Approves 90-Day Extension for Insolvency Resolution Process
Oct 31, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/ Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation
IPO